Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.

Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.

Item
http://www.wikidata.org/entity/Q37813129
Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: profile report.Advances in the design and synthesis of prazosin derivatives over the last ten years.Further evidence of endogenous hydrogen sulphide as a mediator of relaxation in human and rat bladder.Silodosin: treatment of the signs and symptoms of benign prostatic hyperplasia.Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.Silodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia.The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia with α-blockers: focus on silodosin.Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
P2860

Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.

Item
http://www.wikidata.org/entity/Q37813129
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Silodosin for the treatment of ...... d cardiovascular tolerability.
@en
Silodosin for the treatment of ...... d cardiovascular tolerability.
@nl
type
label
Silodosin for the treatment of ...... d cardiovascular tolerability.
@en
Silodosin for the treatment of ...... d cardiovascular tolerability.
@nl
prefLabel
Silodosin for the treatment of ...... d cardiovascular tolerability.
@en
Silodosin for the treatment of ...... d cardiovascular tolerability.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Silodosin for the treatment of ...... d cardiovascular tolerability.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921